Osaic Holdings
MOLN

Osaic Holdings’s Molecular Partners MOLN Stock Holding History

Osaic Holdings’s Portfolio MOLN Stock Details MOLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-200
Closed -$4K – 7393
2021
Q4 		$4K Buy
+200
New +$3.36K ﹤0.01% 6757

Other funds holding MOLN

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Osaic Holdings's MOLN Position: Q1 2022 in Review

Osaic Holdings sold out of Molecular Partners (MOLN) in Q1 2022, closing a stake of 200 shares — an estimated $4K sold.

Osaic Holdings first reported a position in MOLN in Q4 2021 and held it in 1 quarter. The position peaked at $4K in Q4 2021. 8 funds tracked by Wall St. Rank hold MOLN as of Q1 2022.

  • Osaic Holdings reported no remaining Molecular Partners position as of Q1 2022 after selling out during the quarter.
  • Osaic Holdings sold 200 Molecular Partners shares in Q1 2022, an estimated $4K.
  • Osaic Holdings first reported a position in Molecular Partners in Q4 2021 and held it in 1 quarter.
  • Osaic Holdings's Molecular Partners position peaked at $4K in Q4 2021.
  • 8 funds tracked by Wall St. Rank held Molecular Partners as of Q1 2022.

Based on Osaic Holdings's 13F filing for Q1 2022, filed 4 May 2022.